Evidence map›Paper›PMID 35989543›Full record

ArticleJournal of cardiovascular electrophysiology2022

Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation.

Julien Seitz, Théophile Mohr Durdez, Jean P Albenque, André Pisapia, Edouard Gitenay, Cyril Durand, Jacques Monteau, Ghassan Moubarak, Guillaume Théodore, Antoine Lepillier and 14 more

4 registry-linked trialsAbstract read
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04702451 nacompletednot on this map

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

TypeinterventionalSponsorVolta MedicalRan2021 to 2023Enrolled377ConditionsAtrial FibrillationArmsDispersion ablation + PVI, VX1, PVI
NCT05362656 nacompletednot on this map

Preliminary Evaluation of the Artificial Intelligence Software VX1+ for the Detection and Automatic Tagging on 3D Mapping of Spatio-temporal Dispersion Areas During Atrial Fibrillation or Atrial Tachycardia Ablation Procedures.

TypeinterventionalSponsorVolta MedicalRan2022 to 2022Enrolled40ConditionsAtrial Fibrillation, Atrial Tachycardia, Atrial ArrhythmiaArmsVX1+ dispersion mapping
NCT06083012 active not recruitingnot on this mapstarted 2023, after this paper: background citation

Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

TypeobservationalSponsorVolta MedicalRan2023 to 2027Enrolled186ConditionsAtrial Fibrillation, Atrial Arrhythmia, Arrhythmias, CardiacArmsCardiac mapping
NCT06825104 recruitingnot on this mapstarted 2025, after this paper: background citation

Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation

TypeobservationalSponsorVolta MedicalRan2025 to 2027Enrolled278ConditionsAtrial FibrillationArmsVolta AF-Xplorer, Dispersion ablation + PVI, PVI
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  14. Towards advanced regenerative therapeutics to tackle cardio-cerebrovascular diseases.American heart journal plus : cardiology research and practice · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Julien SeitzSt. Joseph Hospital, Marseille, France.ORCID 0000-0001-8499-7167
Théophile Mohr DurdezVolta Medical, Marseille, France.
Jean P AlbenqueClinique Pasteur, Toulouse, France.
André PisapiaSt. Joseph Hospital, Marseille, France.
Edouard GitenaySt. Joseph Hospital, Marseille, France.
Cyril DurandInfirmerie Protestante, Caluire-et-Cuire, France.
Jacques MonteauSt. Joseph Hospital, Marseille, France.
Ghassan MoubarakClinique Ambroise Paré, Neuilly-sur-Seine, France.ORCID 0000-0002-8345-0845
Guillaume ThéodoreUniversity Hospital, Nice, France.
Antoine LepillierCentre Cardiologique du Nord, Saint-Denis, France.
Alexandre ZhaoClinique Ambroise Paré, Neuilly-sur-Seine, France.ORCID 0000-0001-8527-7065
Michel BremondySt. Joseph Hospital, Marseille, France.
Alexandre MaluskiSt. Joseph Hospital, Marseille, France.
Bruno CauchemezClinique Ambroise Paré, Neuilly-sur-Seine, France.
Stéphane CombesClinique Pasteur, Toulouse, France.ORCID 0000-0002-0040-676X
Yves GuyomarSaint-Philibert Hospital, Lomme, France.
Sébastien HeulsSaint-Philibert Hospital, Lomme, France.
Olivier ThomasClinique Ambroise Paré, Neuilly-sur-Seine, France.
Guillaume PenarandaAlphabio laboratory, Marseille, France.
Sabrina SiameSt. Joseph Hospital, Marseille, France.
Anthony AppetitiVolta Medical, Marseille, France.
Paola MilpiedVolta Medical, Marseille, France.
Clément BarsSt. Joseph Hospital, Marseille, France.
Jérôme KalifaBrown University, Providence, Rhode Island, USA.

Funding

Hopital Saint JosephVolta Medical
6 · The paper itself

Abstract

introductionMultiple groups have reported on the usefulness of ablating in atrial regions exhibiting abnormal electrograms during atrial fibrillation (AF). Still, previous studies have suggested that ablation outcomes are highly operator- and center-dependent. This study sought to evaluate a novel machine learning software algorithm named VX1 (Volta Medical), trained to adjudicate multipolar electrogram dispersion.

methodsThis study was a prospective, multicentric, nonrandomized study conducted to assess the feasibility of generating VX1 dispersion maps. In 85 patients, 8 centers, and 17 operators, we compared the acute and long-term outcomes after ablation in regions exhibiting dispersion between primary and satellite centers. We also compared outcomes to a control group in which dispersion-guided ablation was performed visually by trained operators.

resultsThe study population included 29% of long-standing persistent AF. AF termination occurred in 92% and 83% of the patients in primary and satellite centers, respectively, p = 0.31. The average rate of freedom from documented AF, with or without antiarrhythmic drugs (AADs), was 86% after a single procedure, and 89% after an average of 1.3 procedures per patient (p = 0.4). The rate of freedom from any documented atrial arrhythmia, with or without AADs, was 54% and 73% after a single or an average of 1.3 procedures per patient, respectively (p < 0.001). No statistically significant differences between outcomes of the primary versus satellite centers were observed for one (p = 0.8) or multiple procedures (p = 0.4), or between outcomes of the entire study population versus the control group (p > 0.2). Interestingly, intraprocedural AF termination and type of recurrent arrhythmia (i.e., AF vs. AT) appear to be predictors of the subsequent clinical course.

conclusionVX1, an expertise-based artificial intelligence software solution, allowed for robust center-to-center standardization of acute and long-term ablation outcomes after electrogram-based ablation.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsAnti-Arrhythmia AgentsArtificial IntelligenceHumansProspective StudiesRecurrenceSoftwareTreatment OutcomeAnti-Arrhythmia Agentsartificial intelligenceatrial fibrillationcatheter ablationdispersiondrivermappingsinus rhythm

Identifiers

PMID35989543
PMCPMC9826214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.